The inoculation of recombinant VACV expressing the murine B7-1 or B7-2 genes (rVACV-B7-1 or rVACV-B7-2) into immunocompetent mouse models appeared to halt the tumor growth (84). The gene discussed is CD80; the disease is neoplasm.